Susan B.  Washer net worth and biography

Susan Washer Biography and Net Worth

An experienced entrepreneur with a strong scientific and operational background, Sue brings a decade of experience in pharmaceutical management and research with Abbott Labs and Eli Lilly & Company and more than 16 years of senior management experience with entrepreneurial firms in Florida including three start-ups. At AGTC, Sue has successfully secured investments of more than $91 million from nationally recognized venture capitalists and granting agencies; negotiated and closed on a major collaboration with a top five Biotech company; lead the company to complete critical milestones; and recruited an experienced management team. Her experience as a group leader with Abbott’s Diagnostic Division helped hone her skills in bringing new products and technologies from the lab bench into the market place.

Sue sits on the board of the University of Florida’s Center for Entrepreneurship, BioFlorida, Southeast BIO, Gainesville Area Innovation Network, and the Florida High Tech Corridor Council. She has a degree in biochemistry from Michigan State University and an MBA from the University of Florida where she was one of the first graduates from the Warrington College of Business Entrepreneurship program.

What is Susan B. Washer's net worth?

The estimated net worth of Susan B. Washer is at least $8,937.87 as of December 14th, 2018. Ms. Washer owns 22,708 shares of Applied Genetic Technologies stock worth more than $8,938 as of April 16th. This net worth approximation does not reflect any other investments that Ms. Washer may own. Additionally, Ms. Washer receives an annual salary of $747,840.00 as CEO at Applied Genetic Technologies. Learn More about Susan B. Washer's net worth.

How old is Susan B. Washer?

Ms. Washer is currently 61 years old. There are 3 older executives and no younger executives at Applied Genetic Technologies. Learn More on Susan B. Washer's age.

What is Susan B. Washer's salary?

As the CEO of Applied Genetic Technologies Co., Ms. Washer earns $747,840.00 per year. Learn More on Susan B. Washer's salary.

How do I contact Susan B. Washer?

The corporate mailing address for Ms. Washer and other Applied Genetic Technologies executives is 14193 NW 119TH TERRACE SUITE 10, ALACHUA FL, 32615. Applied Genetic Technologies can also be reached via phone at (386) 462-2204 and via email at [email protected]. Learn More on Susan B. Washer's contact information.

Has Susan B. Washer been buying or selling shares of Applied Genetic Technologies?

Susan B. Washer has not been actively trading shares of Applied Genetic Technologies over the course of the past ninety days. Most recently, Susan B. Washer sold 9,950 shares of the business's stock in a transaction on Friday, February 18th. The shares were sold at an average price of $2.18, for a transaction totalling $21,691.00. Learn More on Susan B. Washer's trading history.

Susan B. Washer Insider Trading History at Applied Genetic Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/18/2022Sell9,950$2.18$21,691.00View SEC Filing Icon  
12/14/2018Buy2,380$3.34$7,949.2022,708View SEC Filing Icon  
See Full Table

Susan B. Washer Buying and Selling Activity at Applied Genetic Technologies

This chart shows Susan B Washer's buying and selling at Applied Genetic Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Applied Genetic Technologies Company Overview

Applied Genetic Technologies logo
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase 1/2 clinical trials; and achromatopsia that is in Phase 1/2 clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; preclinical program in dry age-related macular degeneration; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, Inc.; and Otonomy, Inc. The company was incorporated in 1999 and is headquartered in Alachua, Florida.
Read More

Today's Range

Now: $0.39
Low: $0.39
High: $0.39

50 Day Range

MA: $0.39
Low: $0.37
High: $0.42

2 Week Range

Now: $0.39
Low: $0.23
High: $2.83

Volume

N/A

Average Volume

943,490 shs

Market Capitalization

$26.62 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.55